StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.91−0.30 (-9.35%)

Close on Nov 16, 2026Market cap $28.95MP/E –Yield –

Scynexis gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2014 it was 284.9%, against 3.3% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2014Dec 31, 2014284.9%+281.6
FY2013Dec 31, 20133.3%–

More Scynexis figures

See a number that looks wrong?